Statement by James Turley Chairman and CEO of Ernst & Young LLP on the proposed IFRS “Roadmap” webmaster@ey.com (Ernst & Young) Thu, 28 Aug 2008 16:06:43 -0400 Today the U.S. Securities and Exchange Commission took its most significant step toward the adoption of a single set of high quality global accounting and financial reporting standards that everyone can use. The dominant language of financial reporting worldwide is fast becoming IFRS and we applaud the Commission for approving for public comment a proposed “Roadmap.” Webcast: The forward-thinking guide to IFRS revenue recognition webmaster@ey.com (Ernst & Young) Mon, 25 Aug 2008 17:37:28 -0400 On Tuesday, 26 August at 1:00 pm ET, Ernst & Young will host an IFRS webcast to highlight various tactics that may prove useful when negotiating changes specific to revenue recognition while minimizing risk along the way. We invite you to register for our upcoming webcast so you can learn how to undergo this enterprise-wide change. IFRS performs well during market turmoil webmaster@ey.com (Ernst & Young) Mon, 25 Aug 2008 17:20:09 -0400 An SEC-hosted roundtable on 4 August 2008 addressed the use of IFRS during the recent market turmoil. Our takeaway is that IFRS fared well despite challenges in the application of certain IFRS standards. Panelists' comments reflect a growing demand for both a single set of high quality global accounting standards and for IFRS to be that set of standards. Higher commodity prices raising value beyond proven and probable reserves webmaster@ey.com (Ernst & Young) Wed, 20 Aug 2008 17:50:52 -0400 The second publication in this series discusses how mining and metals companies determine the economic value of the estimated cash flows beyond a mine's proven and probable reserves. We consider this issue specifically in the context of higher than historic average commodity prices. Country attractiveness indices 2008 - Q1 & Q2 2008 webmaster@ey.com (Ernst & Young) Tue, 19 Aug 2008 20:45:52 -0400 China displaces the UK in the top five countries in the Ernst & Young renewable energy country attractiveness indices for Q1 and Q2 2008. This is in spite of the UKs renewable energy strategy proposals which are yet to be translated into tangible benefit to the industry. The lead article discusses the impacts of the credit crunch and rising oil prices and their impact on investment in renewable energy. Read the signals webmaster@ey.com (Ernst & Young) Mon, 18 Aug 2008 12:43:31 -0400 Understanding the issues facing your industry is critical to anticipating and alleviating business risk. Ernst & Young offers four Smoke Detector® Reports,which can help you quickly identify key legislative, regulatory and legal news affecting your industry, including corporate compliance, oil and gas, pharmaceutical and medical device, and power and utilities. Each news item is brief, topical and fully cited so you can find the full text of any story that interests you.
CFDA: FDA Latest Warning Letters
WL Issued to NeoChild LLC FDA Tue, 29 Jul 2008 00:00:00 -0400 FDA Warning Letter Issued to NeoChild LLC on 29 Jul 2008 by Dallas District Office WL Issued to G & W Laboratories, Inc. FDA Thu, 24 Jul 2008 00:00:00 -0400 FDA Warning Letter Issued to G & W Laboratories, Inc. on 24 Jul 2008 by New Jersey District Office WL Issued to Husain, Mustafa M, M.D. FDA Wed, 23 Jul 2008 00:00:00 -0400 FDA Warning Letter Issued to Husain, Mustafa M, M.D. on 23 Jul 2008 by Center for Devices and Radiological Health
Associates - Fermentation consultants for biotechnology and nutraceutical companies.
Meta Description: [ Biotechnology consultancy encompassing in-depth surveys on topics, including fermentation, nutraceuticals and feed ingredients; proprietary projects dealing with technology licensing, joint ventures and identification of tolling partners; and workshops on corporate marketing strategy for chemical... ]
3rd Millennium, Inc. - Bioinformatics consulting for pharmaceutical, biotech, and academic clients to design and develop RD software solutions-from Cambridge, MA.
AnaBus - Strategic analytical consulting and knowledge management company focused on the pharmaceutical industry.
BioChemInsights, Inc. - Works with life science businesses to help clients expand their knowledge capital.
BioInfoGen, Inc. - Consulting services for the biotechnology, genomics and pharmaceutical spaces. Full service consulting in LIMS, bioinformatics, infrastructure, database and project management.
Meta Description: [ BioInfoGen offers Management & Technical Consulting services for start-up to mid-cap Biotech, Pharmaceutical, and Medical Device companies. We also provide publications and custom research reports. ]
Campbell Alliance - A management consulting company providing services to pharmaceutical and healthcare companies.
Meta Description: [ Campbell Alliance is a specialized management consulting firm focusing on the pharmaceutical and biotechnology industries. ]
CEBTech Services - Consulting services in fermentation technology, cell culture, bioprocess control, laboratory design, pilot plant design, bioreactor modification, biosensor development, and down stream processing.
Meta Description: [ bioprocess technology, fermentation, cell culture, process control, biosensors, bioreactor modification, down stream processing, laboratory, pilot plant, scale-up ]
Day-to-Eyes BV - Intelligent case report form (intelligent-CRF) is a new electronic data capturing system with interpretation software for clinical research-from Hoofddorp, The Netherlands.
Dyad Systems, LLC - A Cambridge-based, life sciences consulting company providing professional services focused on clinical trial data management and RD data integration solutions.
Enslein Research, Inc. - Develops computational metabolism and toxicity prediction models using advanced QSAR methodologies with extensive metabolism and toxicity databases.
Meta Description: [ ERI develops computational metabolism and toxicity prediction systems, and the attendant data bases, using advanced QSAR methodologies. ERI also solves difficult biostatistics problems. ]
EP Limited - Researches novel diagnostic and therapeutic devices. Also offer a range of consulting services in the fields of biomedical signal processing, design and implementation of digital and analog systems.
Meta Description: [ Diagnostic and Therapeutic Medical Device Development ]
Foresight Consulting LLC - Advanced, unique, customized, medical imaging solutions for pharmaceutical, biotechnology, and medical device clinical development.
Meta Description: [ Advanced medical imaging for the pharmaceutical, medical device, and biotechnology industries.
]
IMS Health - Offers information solutions for pharmaceutical and healthcare industries.
Integrative BioInformatics - Leveraging technology to bridge cell biology and genomics by providing computational biology and database technology software and consulting services for modeling complex biological problems faced by scientists in public and private research institutes, biotechnology companies, and universities.
OnSphere Corporation - eBusiness services with an emphasis on developing FDA compliant solutions for the pharmaceutical industry.
Meta Description: [ Onsphere, Microsoft Gold Partner, sop document management, pharmaceutical
solutions, B2b web application, software development, integration, 21 CFR part
11, FDA compliant, clinical trials, FDA regulation ]
Silico Research - Information technology analysis, consultancy and research for the life sciences
Meta Description: [ Silico Research is an independently owned market research consultancy focusing exclusively on the life science and healthcare sectors ]
Tribiosys, Inc. - Bioinformatics and related RD informatics solutions to improve decision-making in drug discovery and development by the biopharmaceutical industry.
500Validation Commerce LLC - Providing Validation, Protocols, and Compliance solutions for the Pharmaceutical and Biotech world.
Meta Description: [ Validation Commerce - Providing Validation, Protocols, and Compliance solutions for the Pharmaceutical and Biotech world . ]
